Trending NewsTrending NewsNASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis $7.84 -1.01 (-11.36%) As of 12:10 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About LifeStance Health Group Stock (NASDAQ:LFST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LFST alerts:Sign Up Key Stats Today's Range$7.75▼$8.0450-Day Range$6.24▼$8.8552-Week Range$3.74▼$8.89Volume13.09 million shsAverage Volume2.92 million shsMarket Capitalization$3.04 billionP/E Ratio391.95Dividend YieldN/APrice Target$10.00Consensus RatingBuy Company Overview LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans. The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services. Clinicians at LifeStance employ a range of therapeutic approaches—such as cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-informed care—to address conditions including anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and other mental health challenges. Telehealth options further enhance access for patients facing geographic or scheduling limitations. LifeStance partners with health plans, employer-sponsored programs, and governmental payers to integrate its services into broader healthcare ecosystems. These collaborations facilitate in-network access through major insurance carriers and support employer wellness initiatives aimed at improving workforce mental health. Since its inception, the company has expanded both organically and through strategic acquisitions to establish a broad national footprint and meet the increasing demand for outpatient behavioral health services. AI Generated. May Contain Errors. Read More LifeStance Health Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks81st Percentile Overall ScoreLFST MarketRank™: LifeStance Health Group scored higher than 81% of companies evaluated by MarketBeat, and ranked 136th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingBuy Consensus RatingLifeStance Health Group has received a consensus rating of Buy. The company's average rating score is 3.11, and is based on 2 strong buy ratings, 6 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialLifeStance Health Group has a consensus price target of $10.00, representing about 13.0% upside from its current price of $8.85.Amount of Analyst CoverageLifeStance Health Group has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about LifeStance Health Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth100.00% Earnings GrowthEarnings for LifeStance Health Group are expected to grow by 100.00% in the coming year, from $0.09 to $0.18 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is 442.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.37.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is 442.72, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.45.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.74% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 4.24.Change versus previous monthShort interest in LifeStance Health Group has recently decreased by 8.83%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.62 News SentimentLifeStance Health Group has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 18 news articles for LifeStance Health Group this week, compared to 3 articles on an average week.Search Interest4 people have searched for LFST on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $30,775,881.00 in company stock.Percentage Held by Insiders3.20% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LifeStance Health Group's insider trading history. Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFST Stock News HeadlinesLifeStance Health Group, Inc. (NASDAQ:LFST) Receives Consensus Recommendation of "Buy" from BrokeragesMay 8 at 2:45 AM | americanbankingnews.comLifeStance (LFST) Hits 2-Year High as Q1 Profits Soar 1,900%May 7 at 11:54 PM | finance.yahoo.comThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software stocks two months before they crashed this year. Now, he's warning that one AI lab's breakthrough could CRASH the Nasdaq while igniting a $500 trillion wealth transfer. He's found a little-known $40 "pre-IPO backdoor" into the private startup behind this economic sea change.May 8 at 1:00 AM | Chaikin Analytics (Ad)LifeStance Health Group Announces Pricing of Secondary Public OfferingMay 7 at 10:18 PM | globenewswire.comWhy is LifeStance Health Group (LFST) stock rocketing higher todayMay 7 at 6:53 PM | msn.comLifeStance Health Group, Inc. Announces Stockholder Offering of 35 Million Shares and Concurrent Repurchase of 6 Million SharesMay 7 at 5:30 PM | quiverquant.comQLifeStance Health Group (NASDAQ:LFST) Director Robert Bessler Sells 7,752 SharesApril 28, 2026 | insidertrades.comLifeStance Health Group (NASDAQ:LFST) Director Sells $35,758.01 in StockApril 24, 2026 | insidertrades.comSee More Headlines LFST Stock Analysis - Frequently Asked Questions How have LFST shares performed this year? LifeStance Health Group's stock was trading at $7.04 at the beginning of the year. Since then, LFST shares have increased by 11.9% and is now trading at $7.8760. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) released its earnings results on Thursday, May, 7th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.03. The company's quarterly revenue was up 21.2% on a year-over-year basis. Read the conference call transcript. Is LifeStance Health Group doing a stock buyback? LifeStance Health Group's Board of Directors approved a stock buyback program on Wednesday, February 25th 2026, which allows the company to buy back $100,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 3.6% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board believes its stock is undervalued. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an initial public offering on Wednesday, June 9th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? Top institutional shareholders of LifeStance Health Group include Dimensional Fund Advisors LP (2.67%), Jennison Associates LLC (2.64%), Principal Financial Group Inc. (0.79%) and Bank of New York Mellon Corp (0.12%). Insiders that own company stock include Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Warren Gouk, Kevin Michael Mullins, Robert Bessler, Ryan Pardo, Danish J Qureshi, David Bourdon, Ann Varanakis, Anisha Patel-Dunn, Lisa K Miller, Paula Cipollone and Ujjwal Ramtekkar. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LifeStance Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings5/07/2026Today5/08/2026Bank of America Global Healthcare Conference 20265/13/202646th Annual William Blair Growth Stock Conference6/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (8m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 LFST's financial health is in the Green zone, according to TradeSmith. LFST has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealthcare Current SymbolNASDAQ:LFST CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees10,961Year Founded2017Price Target and Rating Average Price Target for LifeStance Health Group$10.00 High Price Target$12.00 Low Price Target$8.00 Potential Upside/Downside+27.0%Consensus RatingBuy Rating Score (0-4)3.11 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$0.02 Trailing P/E Ratio394.40 Forward P/E Ratio87.51 P/E GrowthN/ANet Income$9.66 million Net Margins0.68% Pretax Margin0.87% Return on Equity0.65% Return on Assets0.45% Debt Debt-to-Equity Ratio0.17 Current Ratio1.65 Quick Ratio1.65 Sales & Book Value Annual Sales$1.42 billion Price / Sales2.14 Cash Flow$0.18 per share Price / Cash Flow43.75 Book Value$3.91 per share Price / Book2.01Miscellaneous Outstanding Shares387,830,000Free Float375,418,000Market Cap$3.05 billion OptionableOptionable Beta1.20 Social Links 10 Best Stocks to Own in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NASDAQ:LFST) was last updated on 5/8/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredOne executive order. The biggest wealth transfer of your lifetime.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredThe Death of the Nasdaq?The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...Chaikin Analytics | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | Sponsored‘Please’: OpenAI CEO Sam Altman Begs Small Company for HelpSpaceX 'Dark Energy' Replaces Foreign Oil For years, we've been told SpaceX is a rocket company. But accord...Altimetry | SponsoredIs the SpaceX IPO “Rigged?”The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
